25-Hydroxyvitamin D Levels Are Negatively Associated With Platelets Number in a Cohort of Overweight and Obese Subjects
1 other identifier
observational
341
1 country
1
Brief Summary
This study was aimed to investigate the associations between platelet number and 25(OH)D serum concentration in apparently healthy but overweight/obese subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedFirst Submitted
Initial submission to the registry
October 18, 2019
CompletedFirst Posted
Study publicly available on registry
October 21, 2019
CompletedOctober 21, 2019
October 1, 2019
8 months
October 18, 2019
October 18, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Vitamin D
Vitamin D (ng/mL) concentration in serum
At baseline
Platelets
Platelets (cells/mm3) number in serum
At baseline
Secondary Outcomes (11)
Insulin
At baseline
eGFR (estimated glomerular filtration rate)
At baseline
Creatinin
At baseline
Total cholesterol
At baseline
Thyroid hormones (FT3, FT4)
At baseline
- +6 more secondary outcomes
Eligibility Criteria
Patients who came to the Outpatient Clinic of Nutrition at the National Institute of Gastroenterology "S. de Bellis," Research Hospital, Castellana Grotte, Italy.
You may qualify if:
- Overweight or obesity (BMI\> 25 Kg/m2)
You may not qualify if:
- Any kind of drug
- Hypertension
- Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.),
- Chronic inflammatory diseases
- Renal failure
- Liver failure
- Angina pectoris
- Myocardial infarction and heart failure
- Genetic heart diseases
- Thrombocytopenias
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Gastroenterology IRCCS S. de Bellis
Castellana Grotte, Bari, 70013, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
October 18, 2019
First Posted
October 21, 2019
Study Start
January 1, 2019
Primary Completion
September 1, 2019
Study Completion
September 1, 2019
Last Updated
October 21, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share